scout.yahoo.com
Yahoo Scout
Yahoo Scout
medios怎么读
Searching…
Web results
medios.ag
Creating the leading European Specialty Pharma Platform
This presentation has been produced by Medios AG (the „Company“). The facts and information contained herein are as up to date as is reasonably possible and are subject to revision in the future.
investors.medios.group
Press release Medios expects further growth in revenue and ...
Medios AG is Germany's first listed specialty pharmaceutical company. The shares are listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and are included in the SDAX selection index.
medios.ag
Annual Report - Medios
In implementing these objectives, sustainable behavior is of great importance to Medios. The Sustainability Strategy 2025 is an integral part of the Company’s actions and describes environmental, social and legal aspe...
investors.medios.group
Press release Medios accelerates growth in the first half of ...
Medios AG is Germany's first listed specialty pharmaceutical company. The shares (ISIN: DE000A1MMCC8) are listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard).
cdn.prod.website-files.com
Medios– An offline, smartphone-based artificial intelligence ...
Our aim is to evaluate the performance of an offline AI-based software (Medios Technologies, Singapore) loaded on a smartphone-based fundus camera in the detection of diabetic retinopathy (DR) compared with the image ...
www.luxempart.lu
Press release - luxempart.lu
Medios AG is a pan-European platform focusing on specialty pharmaceuticals for chronic and/or rare diseases. The business activities are centered around wholesale of such drugs and the compounding and supply of patien...
investors.medios.group
201126_Medios_AG_Press_Release_Acquisition Cranach_final
Berlin, 26 November 2020 – Medios AG (“Medios”) today concluded a purchase agreement with BMSH GmbH for the acquisition of the specialized pharmaceutical wholesaler Cranach Pharma GmbH (“Cranach”), Hamburg.